← All investors
Atlas Venture
100 portfolio companies · 4 on the map · $1.8B raised · 3 cities
Portfolio map
4 Atlas Venture portfolio companies on the map.
Portfolio companies

Intellia Therapeutics
Cambridge
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Biotechnology Research$1.7BEst. 2014
NEUROTECH U S A
Cumberland
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.
Biotechnology Research$49.1MMomenta Pharmaceuticals
Cambridge
Momenta Pharmaceuticals, Inc.
Biotechnology ResearchPublic- TN
Trace Neuroscience
South San Francisco
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Biotechnology ResearchSeries AEst. 2024
More portfolio companies
95 more Atlas Venture investments we track beyond the map — 100 tracked in total.
Integral Ad ScienceNew York · Series D
Day One BiopharmaceuticalsSouth San Francisco · Series B
Nimbus TherapeuticsBoston · Private Equity
Alnylam PharmaceuticalsCambridge · Private Equity
Viridian TherapeuticsWaltham · Series C
AAVantgarde BioMilano · Series B
Vigil NeuroscienceCambridge · Series B
Q32 BioCambridge · Post-IPO Equity
Affinia TherapeuticsWaltham · Series C
Right-Hand CybersecurityLewes · Series A
Be BiopharmaCambridge · Series C
K36 TherapeuticsCambridge · Series B
Xilio TherapeuticsWaltham · Series C
Chroma MedicineCambridge · Series B
Antares TherapeuticsBoston · Series A
WorkhumanDublin · Series B
Replimune GroupWoburn · Series B
Sionna TherapeuticsNatick · Series C
Pheon TherapeuticsLondon · Series B
Nvelop TherapeuticsCambridge · Seed
Aiolos BioSan Francisco · Series A
GRO BiosciencesBoston · Series B
InsightSquaredBoston · Series C
VeracodeBurlington · Series F
ZappRxBoston · Series A
IFM TherapeuticsBoston · Venture
ValoreBoston · Series E
BluespecFramingham · Series C
NumerateSan Bruno · Series C
SqrrlCambridge · Series A
Rodin TherapeuticsCambridge · Series C
Generation BioCambridge · Series C
EnglishCentralWilmington · Venture
JeengNew York · Series A
CustomMadeCambridge · Series B
OwnerIQBoston · Series E
KalidoBurlington · Series E
Indalo TherapeuticsSt Louis · Venture
F-Star TherapeuticsCambridge · Post-IPO Equity
Translate BioLexington · Series C
SimpleReachNew York · Series B
Surface OncologyCambridge · Series A
ExelixisAlameda · Seed
InMojiBoston · Seed
EgaletWayne · Post-IPO Equity
DailymotionParis · Series C
MOO.COMLondon · Series A
ArkSan Francisco · Seed
AlltrueSanta Monica · Series A
ColingoSan Francisco · Seed
DisplayLinkPalo Alto · Venture
ChillLos Angeles · Series A
Sirion TherapeuticsTampa · Series B
DiscoverlySan Francisco · Seed
NaviNetBoston · Series C
LivevaultSan Antonio · Series C
U3 PharmaPlanegg · Venture
LearnBoostSan Francisco · Angel
AdnexusWaltham · Series C
HyperwaveGraz · Venture
NextlyCambridge · Seed
FancredBoston · Seed
CLK Design AutomationLittleton · Series B
Ellacoya NetworksMerrimack · Series E
Moreover.comReston · Series A
Apogee PhotonicsAllentown · Venture
UbersenseBoston · Seed
Sequence DesignSanta Clara · Venture
DevelogenGöttingen · Series A
BlueShift TechnologiesAndover · Series B
Orthogon SystemsAshburton · Venture
picoChipBath · Venture
eGroupsSan Francisco · Venture
FireclickSan Diego · Series C
Inspirational StoresParis · Series B
Performix TechnologiesBurlington · Series C
IceraBristol · Private Equity
NetonomyBoston · Series F
NovaMed PharmaceuticalsShanghai · Series B
Realeyes 3DKiel · Series B
ZinwaveCambridge · Venture
DeCODE GeneticsReykjavík · Seed
Vitae PharmaceuticalsFort Washington · Series D
ShoZuLondon · Series C
XytisIrvine · Series B
Marathon TechnologiesLittleton · Series B
SAFE ID SolutionsMunich · Series A
Active EndpointsRedwood City · Series B
MileWiseNew York · Seed
Crucell Holland BVLeiden · Seed
Wavesmith NetworksActon · Series C
Sedona NetworksKanata · Series B
Trebia NetworksActon · Venture
StarbakBurlington · Venture
eRoom TechnologyCambridge · Private Equity
Portfolio map
4 Atlas Venture portfolio companies on the map.